Pathogenetic factors in Sjögren's syndrome: Recent developments

Critical Reviews in Oral Biology and Medicine

Volumn 12, Issue 3, 2001, Pages 244-251

  Esch, T R ^a  

^a FORSYTH INSTITUTE   (United States)

Author keywords

Apoptosis; Autoimmunity; Pathogenesis; Sj gren's syndrome

Indexed keywords

ANTIBODY; CYTOKINE;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; APOPTOSIS; AUTOIMMUNITY; CYTOKINE PRODUCTION; DISEASE COURSE; HUMAN; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; SJOEGREN SYNDROME; T LYMPHOCYTE;

EID: 0034921183     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/10454411010120030301     Document Type: Review

References (48)

1. Analysis of the T-cell receptor Valpha repertoire and cytokine gene expression in Sjögren's syndrome
2. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome
3. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors
4. Sjögren autoantibodies modify neonatal cardiac function via M1 muscarinic acetylcholine receptor activation
5. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin
6. A cautionary note on the use of the TUNEL stain to determine apoptosis
7. Salivary glands: A paradigm for diversity of gland development
8. Leukocytes infiltrating the submandibular glands of NOD mice express E-cadherin
9. Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the alpha and beta type
10. Sjögren's syndrome. Proposed criteria for classification
11. Serum soluble Fas/APO-1 is increased in patients with primary Sjögren's syndrome
12. Preferential localization of CD8+ alpha E beta 7+ T cells around acinar epithelial cells with apoptosis in patients with Sjögren's syndrome
13. Fas and Fas-mediated effects on a human salivary cell line in vitro: A model for immune-mediated exocrine damage in Sjögren's syndrome
14. Analysis of V(H)-D-J(H) gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjögren's syndrome
15. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note
16. Salivary and serum interleukin 6 in primary Sjögren's syndrome
17. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes
18. Altered frequency of type 1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome
19. The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome
20. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren's syndrome through fas-mediated apoptosis
21. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
22. Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome
23. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome
24. TH1 cytokines are produced in labial salivary glands in Sjögren's syndrome, but also in healthy individuals
25. Expression of the mucosal lymphocyte integrin alphaEbeta7 and its ligand E-cadherin in salivary glands of patients with Sjögren's syndrome
26. Quantitative analysis of apoptosis and bcl-2 in Sjögren's syndrome
27. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome
28. Alpha-amylase functions as a salivary gland-specific self T cell epitope in patients with Sjögren's syndrome
29. Single cell analysis of T cells infiltrating labial salivary glands from patients with Sjögren's syndrome
30. Apoptosis in labial salivary glands from Sjögren's syndrome (SS) patients: Comparison with human T lymphotropic virus-1 (HTLV-I)-seronegative and -seropositive SS patients
31. Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome
32. Abundance of NKT-cells in the salivary glands but absence thereof in the liver and thymus of aly/aly mice with Sjögren syndrome
33. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca
34. Modes of epithelial cell death and repair in Sjögren's syndrome (SS)
35. Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome
36. Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-I0
37. Anti-cytoplasmic autoantibodies reactive with epithelial cells of the salivary gland in sera from patients with Sjögren's syndrome: Their disease- and organ-specificities
38. False positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate
39. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome
40. Differential cytokine mRNA expression in human labial minor salivary glands in primary Sjögren's syndrome
41. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome
42. Elevated tear interleukin-6 levels in patients with Sjögren syndrome
43. Expression of the mucosal lymphocyte integrin alpha E beta 7 and its ligand E-cadherin in the synovium of patients with rheumatoid arthritis
44. Anti-alpha-fodrin antibodies in Sjögren syndrome and lupus erythematosus
45. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type J diabetes
46. CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren's syndrome
47. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome
48. Apoptotic cells in the human endometrium and placental villi: Pitfalls in applying the TUNEL method